India's primary market gears up for a blockbuster week with 13 IPOs. Discover key details on Wakefit, ICICI Prudential AMC, Corona Remedies IPOs and SME listings. Get expert insights on the record fundraising trend.
Wakefit Innovations and Corona Remedies IPOs open for subscription on December 8. Check GMP trends, price bands, lot size, and key details for these upcoming mainboard public issues.
SEBI bans DroneAcharya Aerial Innovations & promoters for 2 years, imposes ₹75 lakh fine for IPO fund misuse & fraud. Shares hit 20% lower circuit for second day.
Wakefit Innovations IPO opens Dec 8-10 with a ₹185-195 price band to raise ₹377.1 crore. Funds will fuel store expansion and marketing. Listing expected on Dec 15. Check key dates and details.
Discover how 25 years of International Space Station research revolutionized water filtration, healthcare monitoring, and agricultural techniques benefiting India and global communities. Explore space innovations!
NCB obtains non-bailable warrants against Digital Vision owners in massive ₹600 crore drug diversion case. Key accused involved in international pharmaceutical fraud uncovered in Himachal Pradesh.
Uttar Pradesh government intensifies crackdown on cough syrup smuggling, registers cases against 12 pharmaceutical companies. Investigation reveals interstate smuggling network.
Freudenberg Medical & Filtration Technologies unveil cutting-edge pharmaceutical solutions at CPhI PMEC India 2025, featuring advanced single-use systems and filtration technologies.
Freudenberg Medical & Filtration Technologies unveil cutting-edge pharmaceutical solutions at CPhI PMEC India 2025, featuring advanced drug delivery systems and filtration technologies.
Sudeep Pharma shares surged 33.78% in market debut, exceeding expectations. Analysts advise partial profit booking while maintaining long-term optimism. Read expert views on buy/sell strategy.
Sudeep Pharma shares list on BSE and NSE today after 93.72 times subscription. Grey market signals 20% premium debut. Full details on pricing and investor response.
SMS Pharmaceuticals shares surged 17% after USFDA approved reformulated Ranitidine tablets. The approval marks the drug's return to US market after 5 years, boosting company's growth prospects.
Sudeep Pharma IPO allotment finalized today after massive 93.71x subscription. GMP at ₹87 signals 14.67% listing gain. Track your allotment status now!
20+ Indian startups showcased cutting-edge AI, robotics and clean technology solutions at the UAE-India Startup Corridor in Dubai. Discover how they're shaping the future of tech collaboration.
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
Sudeep Pharma's ₹895 crore IPO witnessed massive demand, subscribed 94 times. QIB portion booked 213x. Shares may list at a 14% premium. Key details inside.
Indian government considers global tenders for patented weight-loss, cancer, and diabetes drugs to ensure patient access. Learn how this move benefits healthcare.
IIT Madras opens its labs for Open House 2026 from Jan 2-4. See 100+ labs, student innovations. Register by Dec 5, 2025. Don't miss this educational showcase!
Indian-American billionaire Vivek Ramaswamy's fortune surges to $1.8B despite political setbacks. Discover how his pharma investments fueled this remarkable growth and his Ohio governor campaign.
Aurobindo Pharma's China facility currently faces $1M loss but aims for break-even by Q3-Q4 FY26. CFO outlines growth drivers including Pen-G ramp-up and biosimilar commercialization.
Karnataka Health Minister Dinesh Gundu Rao urges the pharma sector to adhere to regulations, highlighting critical public health and industry credibility issues.
India-US trade deal negotiations advance with $500 billion bilateral trade target by 2030. Experts reveal which Indian stocks could benefit most from tariff easing.
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
A smallcap pharma stock listed on NSE defied market trends with a 10% surge on November 21, 2024. Discover the driving factors behind this remarkable performance.
Balaxi Pharmaceuticals shares surged 10% to ₹39.5 in intraday trade Friday, defying market weakness. However, the stock remains down 47.42% YTD with retail investors facing significant wealth erosion.
Tragic boiler explosion at pharmaceutical factory in Pakistan's Punjab province claims 15 lives, leaves dozens injured. Emergency response underway.
OPPI Annual Summit 2025 highlights strategic partnerships accelerating India's pharmaceutical transformation. Discover key insights from industry leaders.
Sudeep Pharma's ₹895 crore IPO opens with ₹563-593 price band. Grey market shows ₹130 premium. Analysts recommend long-term investment for 2-5 years horizon.
Sudeep Pharma's ₹895 crore IPO opens today. Price band ₹563-593 per share. Learn about company details, investment minimums & global presence. Subscribe now!
India strengthens ties with Seychelles by delivering 3.5 tonnes of essential medicines. This humanitarian gesture showcases India's commitment to global health partnerships.